Cancer-related and treatment-related fatigue

被引:122
|
作者
Wang, Xin Shelley [1 ]
Woodruff, Jeanie F. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Cancer-related fatigue; Gynecological cancer; Patient-reported outcomes; Brief Fatigue Inventory; DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; PATIENTS RECEIVING CHEMOTHERAPY; RECURRENT EPITHELIAL OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; CLINICAL-TRIALS; CHEMORADIATION THERAPY; MULTIPLE-SCLEROSIS; SYMPTOM BURDEN; FALLOPIAN-TUBE;
D O I
10.1016/j.ygyno.2014.10.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fatigue is a distressing and persistent symptom for patients with gynecological cancer and for survivors. Debilitating cancer-related fatigue (CRF) is produced by both the disease and its treatment. Although awareness and study of CRF have grown in recent years, consistent assessment has not been a priority in routine medical practice. The pathophysiological mechanisms that induce CRF remain unclear, and effective pharmacological interventions have yet to be established. Based on the literature and our own research results, this review focuses on recent progress toward understanding the nature and causes of CRF and on several promising treatment modalities. Given the prevalence and severity of CRF in the gynecological cancer patient population, establishing standardized fatigue measurement and management methods in routine clinical oncology care is of utmost importance. Whether CRF has an underlying inflammatory cause is still hypothetical, however, and no mechanism-driven symptom intervention is currently in clinical use, even though the development of such interventions would provide patients with greater symptom control. Advancing translational and clinical fatigue research will require anatomical pathway studies and well-designed clinical investigations that focus on the development of mechanism-driven interventions based on physiological-behavioral fatigue research, implementation of guidelines for experimental designs, and discovery of biomarkers identifying individuals at high risk for CRF. Validated patient-reported outcomes measures are an essential component of such clinical studies. Because numerous subscales, unidimensional measures, and multidimensional measures exist, clinicians and researchers should consider individual circumstances, good clinical practice, and research goals as guides for choosing the most appropriate fatigue measurement tool. Additionally, education about CRF should be made available to all patients and their caregivers, as accurate and age-appropriate information about conditions like CRF can alleviate much of the stress and anxiety brought on by poor communication about this distressing condition. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 50 条
  • [1] Cancer-related fatigue treatment: An overview
    Mohandas, Hemanth
    Jaganathan, Saravana Kumar
    Mani, Mohan Prasath
    Ayyar, Manikandan
    Thevi, G. V. Rohini
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (06) : 916 - 929
  • [2] Treatment of cancer-related fatigue: an update
    Escalante, CP
    [J]. SUPPORTIVE CARE IN CANCER, 2003, 11 (02) : 79 - 83
  • [3] Assessment and treatment of cancer-related fatigue
    Blickle, Patricia
    Schmidt, Martina E.
    Steindorf, Karen
    [J]. ONKOLOGIE, 2024,
  • [4] Cancer-Related Fatigue: The Approach and Treatment
    Escalante, Carmen P.
    Manzullo, Ellen F.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 412 - 416
  • [5] Treatment of cancer-related fatigue: an update
    Carmen P. Escalante
    [J]. Supportive Care in Cancer, 2003, 11 : 79 - 83
  • [6] Modafinil for the treatment of cancer-related fatigue
    Wirz, S.
    Nadstawek, J.
    Kuehn, K. U.
    Vater, S.
    Junker, U.
    Wartenberg, H. C.
    [J]. SCHMERZ, 2010, 24 (06): : 587 - 595
  • [7] Cancer-Related Fatigue: The Approach and Treatment
    Carmen P. Escalante
    Ellen F. Manzullo
    [J]. Journal of General Internal Medicine, 2009, 24 : 412 - 416
  • [8] Pharmacologic treatment of cancer-related fatigue
    Carroll, Jennifer K.
    Kohli, Sadhna
    Mustian, Karen M.
    Roscoe, Joseph A.
    Morrow, Gary R.
    [J]. ONCOLOGIST, 2007, 12 : 43 - 51
  • [9] Economic consequences of cancer treatment-related fatigue
    不详
    [J]. ONCOLOGY-NEW YORK, 2000, 14 (06): : 934 - 934
  • [10] Cancer-Related Fatigue
    Johnson, Rhonda L.
    Amin, Anjuli R.
    Matzo, Marianne
    [J]. AMERICAN JOURNAL OF NURSING, 2012, 112 (04) : 57 - 60